Cubist Systematic Strategies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.75M Buy
8,800
+5,200
+144% +$2.02M 0.02% 1149
2025
Q2
$1.38M Sell
3,600
-16,500
-82% -$5.95M 0.01% 1766
2025
Q1
$6.95M Buy
20,100
+900
+5% +$289K 0.04% 686
2024
Q4
$5.76M Buy
19,200
+18,400
+2,300% +$6.43M 0.04% 750
2024
Q3
$325K Hold
800
﹤0.01% 2393
2024
Q2
$257K Sell
800
-11,000
-93% -$3.57M ﹤0.01% 2415
2024
Q1
$3.94M Sell
11,800
-23,500
-67% -$7.18M 0.02% 1123
2023
Q4
$9.56M Buy
35,300
+15,500
+78% +$3.83M 0.06% 478
2023
Q3
$4.87M Sell
19,800
-8,800
-31% -$2.41M 0.04% 774
2023
Q2
$8.68M Buy
28,600
+100
+0.4% +$27.8K 0.06% 512
2023
Q1
$7.51M Buy
28,500
+11,700
+70% +$2.97M 0.05% 626
2022
Q4
$4.03M Buy
16,800
+6,100
+57% +$1.37M 0.02% 1218
2022
Q3
$1.97M Buy
+10,700
New +$2.13M 0.01% 2035

Other funds holding HCA

Cubist Systematic Strategies's HCA Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 18,329 shares — an estimated $5.96M sold.

Cubist Systematic Strategies first reported a position in HCA in Q2 2014 and held it in 38 quarters. The position peaked at $25.1M in Q2 2022. 1,156 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 18,329 HCA Healthcare shares in Q2 2024, an estimated $5.96M.
  • Cubist Systematic Strategies first reported a position in HCA Healthcare in Q2 2014 and held it in 38 quarters.
  • Cubist Systematic Strategies's HCA Healthcare position peaked at $25.1M in Q2 2022.
  • 1,156 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.